NDATOPICALOINTMENT
Approved
Feb 2006
Lifecycle
LOE Approaching
Competitive Pressure
15/100
Data completeness
3/8 — Basic
Drug data last refreshed 14h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
VUSION is a topical ointment combining miconazole nitrate (antifungal), zinc oxide (skin protectant), and white petrolatum (emollient) for the treatment of diaper dermatitis. It addresses fungal and irritant components of diaper rash in infants and young children. The mechanism of action for miconazole involves fungal cell membrane disruption, while zinc oxide and petrolatum provide barrier protection and moisture management.
$0.035BPart D
LOE Approaching1.4 years to LOELimited commercial momentum with minimal Part D spending and claims volume signals a small, stable brand team focused on maintenance rather than expansion.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Why This Matters for Your Career
Patent cliff in ~2 years — expect lifecycle management and generic defense hiring
Worked on VUSION at Viatris? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.